Created at Source Raw Value Validated value
April 29, 2022, 10 p.m. oms

1. Recurrent COVID-19 patients, 2. A history of severe allergic reactions, including systemic urticaria and hypersensitivity to vascular edema, 3. Have been treated with plasma SARS-COV-2 antibody during the convalescence of COVID-19, 4. Have received other investigational drugs for sarS-COV-2, 5. Pregnant women, 6. The study physician determines any inappropriateness for participation in the project.

1. Recurrent COVID-19 patients, 2. A history of severe allergic reactions, including systemic urticaria and hypersensitivity to vascular edema, 3. Have been treated with plasma SARS-COV-2 antibody during the convalescence of COVID-19, 4. Have received other investigational drugs for sarS-COV-2, 5. Pregnant women, 6. The study physician determines any inappropriateness for participation in the project.